StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Perspective Therapeutics, Inc.
NYSE American:CATX
Sector
Location
Market Cap
USD 319.92 M
Share Price
USD 4.31
Avg Daily Volume
1,156,041
Change (1 day)
2.62%
Change (1 year)
-65.90%
Change (YTD)
35.11%
Perspective Therapeutics, Inc. Shareholders' Equity for the year ending December 31, 2024: USD 290.67 M
Perspective Therapeutics, Inc. Shareholders' Equity is USD 290.67 M for the year ending December 31, 2024, a 286.63% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.
-
Perspective Therapeutics, Inc. Shareholders' Equity for the year ending December 31, 2023 was USD 75.18 M, a 37.58% change year over year.
-
Perspective Therapeutics, Inc. Shareholders' Equity for the year ending December 31, 2022 was USD 54.64 M, a -10.83% change year over year.
-
Perspective Therapeutics, Inc. Shareholders' Equity for the year ending June 30, 2022 was USD 61.28 M, a -9.09% change year over year.
-
Perspective Therapeutics, Inc. Shareholders' Equity for the year ending June 30, 2021 was USD 67.41 M, a 1,077.81% change year over year.
Competitors
Boston Scientific Corporation
USD 103.78
BSX
+0.14
0.14%
Siemens Healthineers AG
USD 53.54
SHL.DE
-0.07
-0.12%
GE HealthCare Technologies Inc.
USD 74.16
GEHC
-1.80
-2.37%
Laboratory Corporation of America Holdings
USD 243.04
LH
-0.68
-0.28%
Natera, Inc.
USD 140.63
NTRA
+1.73
1.25%
Baxter International Inc.
USD 27.37
BAX
-0.40
-1.44%
Torrent Pharmaceuticals Limited
USD 40.49
TORNTPHARM.NS
-0.35
-0.85%
ICON Public Limited Company
USD 139.63
ICLR
-3.91
-2.72%
Ascendis Pharma A/S
USD 168.02
ASND
-1.88
-1.11%
Exact Sciences Corporation
USD 48.36
EXAS
-2.10
-4.16%
Regencell Bioscience Holdings Limited
USD 14.40
RGC
-0.10
-0.69%
ConvaTec Group Plc
USD 3.24
CTEC.L
+0.05
1.61%
Hangzhou Tigermed Consulting Co., Ltd.
USD 6.44
3347.HK
-0.07
-1.01%
Shenzhen New Industries Biomedical Engineering Co., Ltd.
USD 7.57
300832.SZ
-0.03
-0.36%
DiaSorin S.p.A.
USD 104.03
DIA.MI
-1.17
-1.11%
Guardant Health, Inc.
USD 45.64
GH
-0.82
-1.76%
APT Medical Inc.
USD 41.27
688617.SS
+0.88
2.18%
Laurus Labs Limited
USD 9.56
LAURUSLABS.NS
-0.06
-0.57%
Lantheus Holdings, Inc.
USD 71.56
LNTH
+1.38
1.97%
Ipca Laboratories Limited
USD 16.77
IPCALAB.NS
-0.23
-1.33%
Key Data
| Date | Shareholders' Equity | Cash and Short-Term Investments | Receivables | Inventory |
|---|
Competitors
Boston Scientific Corporation
USD 103.78
BSX
+0.14
0.14%
Siemens Healthineers AG
USD 53.54
SHL.DE
-0.07
-0.12%
GE HealthCare Technologies Inc.
USD 74.16
GEHC
-1.80
-2.37%
Laboratory Corporation of America Holdings
USD 243.04
LH
-0.68
-0.28%
Natera, Inc.
USD 140.63
NTRA
+1.73
1.25%
Baxter International Inc.
USD 27.37
BAX
-0.40
-1.44%
Torrent Pharmaceuticals Limited
USD 40.49
TORNTPHARM.NS
-0.35
-0.85%
ICON Public Limited Company
USD 139.63
ICLR
-3.91
-2.72%
Ascendis Pharma A/S
USD 168.02
ASND
-1.88
-1.11%
Exact Sciences Corporation
USD 48.36
EXAS
-2.10
-4.16%
Regencell Bioscience Holdings Limited
USD 14.40
RGC
-0.10
-0.69%
ConvaTec Group Plc
USD 3.24
CTEC.L
+0.05
1.61%
Hangzhou Tigermed Consulting Co., Ltd.
USD 6.44
3347.HK
-0.07
-1.01%
Shenzhen New Industries Biomedical Engineering Co., Ltd.
USD 7.57
300832.SZ
-0.03
-0.36%
DiaSorin S.p.A.
USD 104.03
DIA.MI
-1.17
-1.11%
Guardant Health, Inc.
USD 45.64
GH
-0.82
-1.76%
APT Medical Inc.
USD 41.27
688617.SS
+0.88
2.18%
Laurus Labs Limited
USD 9.56
LAURUSLABS.NS
-0.06
-0.57%
Lantheus Holdings, Inc.
USD 71.56
LNTH
+1.38
1.97%
Ipca Laboratories Limited
USD 16.77
IPCALAB.NS
-0.23
-1.33%